The IL-1β production in the groups that received some treatment is highlighted, as reported by Piaggio et al., who point out that IL-1β exhibits proinflammatory activity during BNZ treatment, as well as it is involved in immune protection by intracellular pathogens infections; therefore, IL-1β is indicative of an effective adaptive immune response [50]. This evidence concerns the gene IL1B and infection.